| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 83 | 14.659 | 39.829 | 4.879 | 482 |
| Total Income - EUR | - | - | - | - | - | 424 | 19.751 | 39.829 | 19.584 | 10.001 |
| Total Expenses - EUR | - | - | - | - | - | 507 | 14.865 | 20.692 | 14.659 | 14.255 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -83 | 4.886 | 19.137 | 4.926 | -4.254 |
| Net Profit/Loss - EUR | - | - | - | - | - | -86 | 4.832 | 18.749 | 4.879 | -4.267 |
| Employees | - | - | - | - | - | 0 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Neuroklinik Center S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 29.204 | 68.350 | 58.961 | 49.210 | 39.416 |
| Current Assets | - | - | - | - | - | 81.730 | 21.666 | 48.335 | 37.605 | 31.119 |
| Inventories | - | - | - | - | - | 98 | 1.360 | 1.394 | 1.389 | 0 |
| Receivables | - | - | - | - | - | 76.861 | 10.176 | 11.405 | 11.330 | 7.509 |
| Cash | - | - | - | - | - | 4.771 | 10.130 | 35.536 | 24.886 | 23.610 |
| Shareholders Funds | - | - | - | - | - | -44 | 4.788 | 23.552 | 28.359 | 23.934 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 34.459 | 15.497 | 13.797 | 3.426 | 1.398 |
| Income in Advance | - | - | - | - | - | 76.520 | 69.730 | 69.947 | 55.029 | 45.203 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8695 - 8695" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Neuroklinik Center S.r.l.